The Endocrine Society's Journals, led by Endocrine Reviews, earned higher impact factors in 2021, according to Clarivate’s annual Journal Citation Report (JCR) for 2021. The Society ranked fourth by average Impact Factor among 47 publishers in Clarivate’s ‘Endocrinology & Metabolism’ scientific category.
Endocrine Reviews led the Society’s journals, with its Impact Factor rising to 25.261 from 19.871 in 2021. This year marks the journal’s highest Impact Factor since 2001. The journal publishes bimonthly comprehensive, authoritative, and timely review articles balancing both experimental and clinical endocrinology themes.
The Society's flagship basic science journal, Endocrinology, increased its Impact Factor from 4.736 to 5.051. Endocrinology, founded over 100 years ago, provides insights into the physiological and pathophysiological processes relevant to endocrine systems and endocrine-related diseases at the molecular, cellular, tissue, and organismal level of hormone function.
The Journal of Clinical Endocrinology and Metabolism (JCEM) saw its Impact Factor increase from 5.958 to 6.134. JCEM is the world's leading peer-reviewed endocrine clinical research and clinical practice journal. The Society's open-access Journal of the Endocrine Society, launched in 2017, is a candidate to receive its first Impact Factor next year.
The Society plans to launch a new open-access journal, JCEM Case Reports, later this year. Society Past President William F. Young will serve a three-year term as the journal's inaugural Editor-in-Chief.
Click here to read the original press release.
